EUmetriosis: Insights Into the Pathogenesis of Endometriosis

Recruiting N/A Interventional Study
Endometriosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 56
Sex
Female
Study type
Interventional
Purpose
Diagnostic
Participants needed
60 (estimated)
Sponsor
Université Catholique de Louvain · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Premenopausal * In spontaneous menstrual cycle (no hormonal treatments for the last 3 months) * Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy Exclusion Criteria: * HIV or Hepatitis positive * Pregnancy
Contacts

Marie-Madeleine Dolmans, MD, PhD

+32 (0)2 764 5287

marie-madeleine.dolmans@uclouvain.be

CONTACT